Lexington, MA – According to filings with the U.S. Securities and Exchange Commission, Hyalex Orthopaedics is raising $34,866,680.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Mira Sahney played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Hyalex Orthopaedics
Hyalex Orthopaedics is a venture backed Boston-based medical device start-up focused on developing and commercializing new products that feature HYALEX materials technology. Unlike other polymers, synthetic HYALEX material has the unique capability of maintaining low friction and low wear under the high loads encountered in human joints. Hyalex Orthopaedics products are in the development stage and have not been approved for use in humans by any regulatory agency.

To learn more about Hyalex Orthopaedics, visit http://www.hyalex.com/

Contact:
Mira Sahney, President and Chief Executive Officer
781-778-3232
mira@hyalex.com
https://www.linkedin.com/in/mirasahney/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved